nuplazid

Generic: pimavanserin tartrate

Labeler: acadia pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name nuplazid
Generic Name pimavanserin tartrate
Labeler acadia pharmaceuticals inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

pimavanserin tartrate 34 mg/1

Manufacturer
Acadia Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 63090-340
Product ID 63090-340_1dd0d414-c321-447c-8810-458c5b52edc2
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA210793
Listing Expiration 2026-12-31
Marketing Start 2018-06-28

Pharmacologic Class

Classes
atypical antipsychotic [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 63090340
Hyphenated Format 63090-340

Supplemental Identifiers

RxCUI
2049269 2049271 2049275 2049278
UPC
0363090100303 0363090340303
UNII
NA83F1SJSR

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name nuplazid (source: ndc)
Generic Name pimavanserin tartrate (source: ndc)
Application Number NDA210793 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 34 mg/1
source: ndc
Packaging
  • 30 CAPSULE in 1 BOTTLE, PLASTIC (63090-340-30)
source: ndc

Packages (1)

Ingredients (1)

pimavanserin tartrate (34 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "1dd0d414-c321-447c-8810-458c5b52edc2", "openfda": {"upc": ["0363090100303", "0363090340303"], "unii": ["NA83F1SJSR"], "rxcui": ["2049269", "2049271", "2049275", "2049278"], "spl_set_id": ["1e6bea44-57d6-4bac-9328-46e1ee59f83b"], "manufacturer_name": ["Acadia Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE, PLASTIC (63090-340-30)", "package_ndc": "63090-340-30", "marketing_start_date": "20180628"}], "brand_name": "NUPLAZID", "product_id": "63090-340_1dd0d414-c321-447c-8810-458c5b52edc2", "dosage_form": "CAPSULE", "pharm_class": ["Atypical Antipsychotic [EPC]"], "product_ndc": "63090-340", "generic_name": "pimavanserin tartrate", "labeler_name": "Acadia Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NUPLAZID", "active_ingredients": [{"name": "PIMAVANSERIN TARTRATE", "strength": "34 mg/1"}], "application_number": "NDA210793", "marketing_category": "NDA", "marketing_start_date": "20180628", "listing_expiration_date": "20261231"}